Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,924 | -5,588 | -5,751 | -6,537 | -4,074 |
| Depreciation Amortization | 553 | 561 | 510 | 420 | 436 |
| Accounts receivable | -93 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,381 | -235 | 499 | 349 | 269 |
| Other Working Capital | 2,058 | 482 | 1,519 | 1,042 | 432 |
| Other Operating Activity | 902 | 1,552 | 551 | 1,542 | 126 |
| Operating Cash Flow | $-3,122 | $-3,228 | $-2,672 | $-3,184 | $-2,811 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -408 | -167 | -11 | -3 | 14 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,000 | N/A |
| Other Investing Activity | -75 | 0 | 0 | -1,000 | 0 |
| Investing Cash Flow | $-483 | $-167 | $-11 | $-1,003 | $14 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,210 | 795 | 1,454 | 2,266 | 2,963 |
| Debt Repayment | -5 | -202 | -6 | -75 | -308 |
| Common Stock Issued | 2,298 | 2,718 | 1,411 | 1,925 | 200 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -4 |
| Other Financing Activity | 177 | -25 | 25 | 0 | 0 |
| Financing Cash Flow | $3,680 | $3,286 | $2,884 | $4,116 | $2,850 |
| Beginning Cash Position | 92 | 201 | 0 | 72 | 18 |
| End Cash Position | 167 | 92 | 201 | 0 | 72 |
| Net Cash Flow | $75 | $-109 | $201 | $-71 | $53 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,122 | -3,228 | -2,672 | -3,184 | -2,811 |
| Capital Expenditure | -408 | -168 | -11 | -3 | -18 |
| Free Cash Flow | -3,530 | -3,396 | -2,684 | -3,187 | -2,829 |